Innovator IBD 50 ETF (NYSEARCA:FFTY) Sees Large Increase in Short Interest

Innovator IBD 50 ETF (NYSEARCA:FFTY – Get Free Report) was the target of a large growth in short interest in the month of October. As of October 30th, there was short interest totaling 34,755 shares, a growth of 382.4% from the October 15th total of 7,205 shares. Currently, 2.0% of the company’s shares are sold short. Based on an average trading volume of 36,072 shares, the short-interest ratio is currently 1.0 days.

Innovator IBD 50 ETF Trading Up 0.2%

Shares of NYSEARCA:FFTY traded up $0.07 during mid-day trading on Friday, reaching $29.09. The stock had a trading volume of 2,511 shares, compared to its average volume of 49,397. The firm has a 50 day simple moving average of $33.71 and a two-hundred day simple moving average of $37.15. Innovator IBD 50 ETF has a twelve month low of $28.62 and a twelve month high of $44.08. The firm has a market cap of $50.91 million, a PE ratio of 12.03 and a beta of 1.50.

Institutional Investors Weigh In On Innovator IBD 50 ETF

Several large investors have recently bought and sold shares of the company. Guardian Wealth Advisors LLC NC bought a new position in shares of Innovator IBD 50 ETF during the second quarter worth $507,000. Kraematon Investment Advisors Inc. acquired a new position in shares of Innovator IBD 50 ETF in the 2nd quarter valued at $1,021,000. Royal Bank of Canada increased its position in shares of Innovator IBD 50 ETF by 3,222.5% in the 1st quarter. Royal Bank of Canada now owns 18,274 shares of the company’s stock valued at $611,000 after buying an additional 17,724 shares in the last quarter. Concurrent Investment Advisors LLC increased its position in shares of Innovator IBD 50 ETF by 11.1% in the 2nd quarter. Concurrent Investment Advisors LLC now owns 63,128 shares of the company’s stock valued at $3,349,000 after buying an additional 6,321 shares in the last quarter. Finally, KFG Wealth Management LLC bought a new stake in shares of Innovator IBD 50 ETF in the 2nd quarter valued at $201,000.

Innovator IBD 50 ETF Company Profile

(Get Free Report)

The Innovator IBD 50 ETF (FFTY) is an exchange-traded fund that is based on the IBD 50 index. The fund tracks an index of 50 US-listed stocks with aggressive growth characteristics. Holdings are selected based on fundamental and technical rankings FFTY was launched on Apr 9, 2015 and is managed by Innovator.

See Also

Receive News & Ratings for Innovator IBD 50 ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innovator IBD 50 ETF and related companies with MarketBeat.com's FREE daily email newsletter.